노바백스 (NVAX)

Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal

Zacks Investment Research

Meme Mania is Back: Buy these 3 Stocks

Zacks Investment Research

Company News For May 13, 2024

Zacks Investment Research

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)

Benzinga

Why Novavax Stock More Than Doubled Today

The Motley Fool

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?

Benzinga

US Stocks Set To End Week Strong With S&P 500 Eyeing Break Above Late-March Peak: Analyst Says He's Still A Buy In May Amid This Positive Signal

Benzinga

Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research

Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts

The Motley Fool

Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know

Zacks Investment Research

What's in the Cards for Amgen (AMGN) This Earnings Season?

Zacks Investment Research

3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole

The Motley Fool

How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?

Zacks Investment Research

Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings

Zacks Investment Research

These Biotech Stocks Could Soar 120% and 295%, According to Wall Street

The Motley Fool

What's in Store for Biogen (BIIB) This Earnings Season?

Zacks Investment Research

Better Buy: Bluebird Bio Vs. Novavax

The Motley Fool

J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?

Zacks Investment Research

Down 60% From Its 52-Week High, Is Novavax Stock a Buy?

The Motley Fool

Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?

Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Investment Research

1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague

The Motley Fool

Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research

Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study

Zacks Investment Research

1 Beaten-Down Stock That's Still Not Worth Buying

The Motley Fool

Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street

The Motley Fool

Is Novavax a Buy Now?

The Motley Fool

1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?

The Motley Fool

Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks

Zacks Investment Research

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Novavax (NVAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates

Zacks Investment Research

Has Novavax Just Solved Its Biggest Problem?

The Motley Fool

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Zacks Investment Research

Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?

Zacks Investment Research

Identifying Trends With Penny Stocks; How to Guide

PennyStocks

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday

Benzinga

Better Bull Market Buy: Novavax vs. Pfizer

The Motley Fool

Novavax (NVAX) Q4 Earnings Preview: What's in the Cards?

Zacks Investment Research

Where Will Novavax Be in 10 Years?

The Motley Fool

3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market

The Motley Fool

Better Recovery Story Buy: Novavax vs. Teladoc

The Motley Fool

Could Novavax Stock Help You Become a Millionaire?

The Motley Fool

3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts

The Motley Fool

1 Reason to Buy Novavax Stock, and 3 (Better) Reasons to Sell

The Motley Fool

1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell

The Motley Fool

Is It Too Late to Buy Novavax Stock?

The Motley Fool

Where Will Novavax Be in 5 Years?

The Motley Fool